Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/278,912external-prioritypatent/US20030114394A1/en
Application filed by Columbia Lab Bermuda LtdfiledCriticalColumbia Lab Bermuda Ltd
Publication of CO5580799A2publicationCriticalpatent/CO5580799A2/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
1.- Una composición vaginal farmacéutica para tratar o evitar el dolor pélvico, para tratar o mejorar la infertilidad, asociada con disritmia uterina que comprende una cantidad terapéuticamente efectiva de un agente tratante anti-disrítmico o un portador bioadhesivo de liberación extendida farmacéuticamente aceptable.2.- La composición de la reivindicación 1, en donde el portador comprende un polímero de ácido policarboxílico reticulado bioadhesivo, hinchable en agua, insoluble en agua.3.- La composición de la reivindicación 2, en donde el polímero comprende policarbofilo.1. A pharmaceutical vaginal composition for treating or avoiding pelvic pain, for treating or improving infertility, associated with uterine dysrhythmia comprising a therapeutically effective amount of an anti-dysrhythmic treating agent or a pharmaceutically acceptable bioadhesive extended-release carrier. The composition of claim 1, wherein the carrier comprises a bioadhesive, water-insoluble, water-insoluble crosslinked polycarboxylic acid polymer. 3. The composition of claim 2, wherein the polymer comprises polycarbophil.
CO04048777A2001-10-292004-05-26
VAGINALLY ADMINISTRATED ANTI-DISRITMIC AGENTS TO TREAT PELVIC PAIN AND INFERTILITY
CO5580799A2
(en)
Process for treating a human female suffering from dysmenorrhea, pharmaceutically acceptable composition, and device for delivering a pharmaceutical agent to a female uterus
Method for treating human females, pharmaceutically acceptable composition and device for intravaginal or transvaginal application of an antifungal, antiviral, antibacterial or parasiticidal pharmaceutical agent
BIOADHESIVE PHARMACEUTICAL COMPOSITION OF GRADUAL HYDRATION AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE ADMINISTRATION OF TESTOSTERONE AND TERBUTALINE TO A MAMMER THROUGH A MUCOSA SURFACE.